HomeMarketUltragenyx downgraded to neutral at Goldman Sachs on setrusumab data Posted in MarketUltragenyx downgraded to neutral at Goldman Sachs on setrusumab data March 24, 2026 Reporter Ultragenyx downgraded to neutral at Goldman Sachs on setrusumab data Source link
